Stock search

Ticker or company name

Quest Diagnostics

DGX · NYSE · Health Care

$262,21Up +2,61 (+1,01%)today

Quotes delayed up to 15 min. Updated 16 Nov, 16:00 New York time

Market cap
$28,7 bn
Div. yield
2,1%
Year to date
+49,6%
52 weeks: $171,18$262,00

Ratio score

61/100
Ratio would watch

based on 9 metrics as of 16.11.2026 ·

Verdict by our methodology based on current metrics. Not an investment recommendation.

Key metrics

3 ✓ · 5 — · 1 ✕ · 1 n/a · hover over a row or tap it to see the trend

All metrics

MetricValue5-year medianIndustry median
P/E TTM25,519,425,1
Forward P/E21,3—16,2
PEG2,6—2,2
P/S2,41,72,2
EV/EBITDA17,914,517,3
P/FCF20,9—19,5
P/B3,82,63,4

Industry median — across 33 profitable companies in “Health Care” in Ratio. Revenue and EPS forecasts for future years and the number of employees are in the paid data plan.

Price chart

Compare with

Choose a stock

Closing prices adjusted for splits and dividends. The S&P 500 index and the intraday chart come later.

Analysts

Ratings, 23 analysts

Buy
12
Hold
11
Sell
0

Beat the EPS forecast in 4 of the last 4 quarters

QuarterEstimateActualSurprise
Q3 20262,893,00Up +3,7%
Q2 20262,853,12Up +9,3%
Q1 20262,372,50Up +5,5%
Q4 20252,382,42Up +1,5%

Price targets and yearly revenue and EPS forecasts are in the paid data plan. These are analysts' opinions, not our verdict.

Financials in charts

MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23
Revenue3,10 bn3,04 bn2,90 bn2,81 bn2,82 bn2,76 bn2,65 bn2,62 bn2,49 bn2,40 bn2,37 bn2,29 bn
EPS2,782,842,242,182,162,471,941,951,992,031,721,70
Margin10,1%10,5%8,7%8,7%8,7%10,2%8,3%8,5%9,1%9,6%8,2%8,4%
FCF445 m459 m164 m307 m419 m436 m197 m341 m250 m268 m50,0 m455 m

From SEC reports. TTM is the sum of 4 quarters; a year is TTM at the end of the calendar year. Forecast bars are in the paid data plan.

Owners

Ownership structure and major holders (13F filings) are in the paid data plan. They are not part of the score or the traffic light.

Insider trades over 12 months

Over 12 months: no purchases, sales $45,8 m.

NameAmountSharesPrice
plewman patrick9 Nov 2026 · sale$167 271650$257,34
plewman patrick9 Nov 2026 · sale$1,75 m6 793$257,34
plewman patrick9 Nov 2026 · sale$1,10 m4 274$257,34
doherty catherine t.3 Nov 2026 · sale$730 3512 907$251,24
doherty catherine t.3 Nov 2026 · sale$720 6552 877$250,49
doherty catherine t.3 Nov 2026 · sale$749 2083 004$249,40
doherty catherine t.3 Nov 2026 · sale$585 6892 358$248,38
doherty catherine t.3 Nov 2026 · sale$284 2781 151$246,98
doherty catherine t.3 Nov 2026 · sale$1,48 m5 990$246,26
doherty catherine t.3 Nov 2026 · sale$937 1353 818$245,45
pfeiffer gary m26 Oct 2026 · sale$292 3291 203$243,00
davis j. e.1 Sep 2026 · sale$2,43 m10 000$242,72
prevoznik michael e28 Aug 2026 · sale$105 141430$244,51
prevoznik michael e28 Aug 2026 · sale$1,52 m6 237$243,63
prevoznik michael e28 Aug 2026 · sale$3,89 m16 010$242,88

SEC Form 4. Titles and trading plans are not in the data. They are not part of the score or the traffic light.

About the company

Industry
Health Care
Exchange
NYSE
Country
US
IPO date
17 Dec 1996

Company description, revenue by segment and region, and the CEO will come later.

Next report
date not announced

An AI summary of the earnings call will come later.

Peers

CompanyPrice
LHLabcorp$372,4656would watch30,0+6,0%6,9%
DXCMDexcom$81,6189would consider31,4+13,0%19,4%
STESteris$261,9175would consider31,9+8,1%13,4%
RMDResMed$238,1983would consider21,3+9,0%27,8%
CNCCentene Corporation$74,7772would consider24,2+9,7%0,7%
Compare with peers

Ratio — a score by our methodology, not an investment recommendation.